Search research articles
Contact Us
Filters
Showing results (131-140 of 247) with videos related to
Page
of 25
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 21, 2007
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations
Valentina Tomassini, Saad Jbabdi, Johannes C Klein, et al.
Brain : a Journal of Neurology
|
May 20, 2005
A longitudinal fMRI study on motor activity in patients with multiple sclerosis
Patrizia Pantano, Caterina Mainero, Delia Lenzi, et al.
Frontiers in Neurology
|
April 11, 2019
Functional Connectivity Changes After Initial Treatment With Fingolimod in Multiple Sclerosis
Nikolaos Petsas, Laura De Giglio, Vicente González-Quintanilla, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 25, 2012
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course
Emilia Sbardella, Anita Greco, Maria L Stromillo, et al.
Magnetic Resonance Imaging
|
September 11, 2002
A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis
Francesca Caramia, Patrizia Pantano, Silvia Di Legge, et al.
Therapeutic Advances in Neurological Disorders
|
July 12, 2023
Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4
Diego Centonze, Maria Pia Amato, Vincenzo Brescia Morra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 21, 2016
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy
Alice Laroni, Davide Brogi, Vincenzo Brescia Morra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 21, 2015
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads
Luca Prosperini, Pietro Annovazzi, Marco Capobianco, et al.
BMC Neurology
|
April 3, 2014
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial
Alice Laroni, Davide Brogi, Vincenzo Brescia Morra, et al.
CNS Drugs
|
December 21, 2016
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial
Laura De Giglio, Fabiana Marinelli, Valeria T Barletta, et al.
Page
of 25
Search research articles
Search
Showing results (131-140 of 247) with videos related to
Sort By:
Page
of 25
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 21, 2007
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations
Valentina Tomassini, Saad Jbabdi, Johannes C Klein, et al.
Brain : a Journal of Neurology
|
May 20, 2005
A longitudinal fMRI study on motor activity in patients with multiple sclerosis
Patrizia Pantano, Caterina Mainero, Delia Lenzi, et al.
Frontiers in Neurology
|
April 11, 2019
Functional Connectivity Changes After Initial Treatment With Fingolimod in Multiple Sclerosis
Nikolaos Petsas, Laura De Giglio, Vicente González-Quintanilla, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 25, 2012
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course
Emilia Sbardella, Anita Greco, Maria L Stromillo, et al.
Magnetic Resonance Imaging
|
September 11, 2002
A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis
Francesca Caramia, Patrizia Pantano, Silvia Di Legge, et al.
Therapeutic Advances in Neurological Disorders
|
July 12, 2023
Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4
Diego Centonze, Maria Pia Amato, Vincenzo Brescia Morra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 21, 2016
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy
Alice Laroni, Davide Brogi, Vincenzo Brescia Morra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 21, 2015
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads
Luca Prosperini, Pietro Annovazzi, Marco Capobianco, et al.
BMC Neurology
|
April 3, 2014
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial
Alice Laroni, Davide Brogi, Vincenzo Brescia Morra, et al.
CNS Drugs
|
December 21, 2016
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial
Laura De Giglio, Fabiana Marinelli, Valeria T Barletta, et al.
Page
of 25